×
ACR 2020 Frequently Asked Questions
https://www.rheumatology.org/Annual-Meeting/Resources

Sep 6th, 2020 - Please refer to the Frequently Asked Questions (FAQs) below for more information on the all-virtual ACR Convergence 2020. We will share more details as they become available in the coming weeks and months.

ACR 2020 Permissions and Reprints
https://www.rheumatology.org/Annual-Meeting/Abstracts/Permissions-and-Reprints

Sep 6th, 2020 - ACR Convergence, the ACR's annual meeting, is a private event. Programs presented at the meeting are for the education of attendees and purchasers of recorded presentations as authorized by the American College of Rheumatology. The information and materials displayed and presented during this meeting are the property of the ACR and the presenter and cannot be photographed, copied, photocopied, ...

ACR 2020 General Meeting Information
https://www.rheumatology.org/Annual-Meeting/Resources/General-Meeting-Information

ACR Convergence, the American College of Rheumatology’s 2020 annual meeting will be in Washington, D.C. November 6 - 11.

ACR/ARHP 2020 American College of Rheumatology Annual Meeting 2020
https://acr-arhp2020.org/

American College of Rheumatology Annual Meeting 2020 06-11 November 2020 Washington DC.

ACR 2020 Abstract Embargo Policies
https://www.rheumatology.org/Annual-Meeting/Abstracts/Embargo-Policies

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new ...

ACR 2020 Online Program
https://plan.core-apps.com/tristar_acr20/customScreen/aboutACR20Program

The Online Program is your source for educational content and program information for the 2020 ACR/ARP Annual Meeting. Look for topics of interest, bookmark sessions, and/or create a customized itinerary. Use the navigation menu to browse sessions, faculty, abstracts, and other meeting content. You can also use the advanced search tool to find sessions.

ACR 2020 Contacts
https://www.rheumatology.org/Annual-Meeting/Resources/Annual-Meeting-Contacts

Registration and Hotels, Education, Abstracts, Exhibits, Press

ACR 2020 Abstracts
https://www.rheumatology.org/Annual-Meeting/Abstracts

Submission, presentation, permission/reprints, embargo, ACR Convergence Awards

ACR 2020 Program
https://www.rheumatology.org/Annual-Meeting/Program

The program has hundreds of sessions to educate professionals in every segment of rheumatology.

ACR 2020 Image Competition Guidelines & Procedures PDF
https://www.rheumatology.org/Portals/0/Files/Image-Competition-Guidelines.pdf

The American College of Rheumatology (ACR) and the Association of Rheumatology Professionals(ARP) invite you to submit a case-based image and take advantage of the opportunity to have your work peer-reviewed by experts in the field. If accepted, your image will be digitally displayed in the distinguished international venue of ACR Convergence 2020 and be added to the ACR Rheumatology Image Libr...

ACR 2020 Image Competition
https://www.rheumatology.org/Annual-Meeting/Program/Image-Competition

Call for Images, Submission Eligibility, Timeline, Permissions

Be proactive in fracture prevention
https://www.mdedge.com/rheumatology/article/214488/osteoporosis/be-proactive-fracture-prevention?channel=53
Elizabeth Shane, MD

Dec 18th, 2019 - Several studies published over the last few years have shown declining rates of diagnosis and treatment of osteoporosis in older adults. In part, this may be due to declining ability to diagnose osteoporosis because declining reimbursement for dual x-ray absorptiometry has made it less available to patients and doctors.

Osteoporotic fracture risk is undermanaged in older adults
https://www.mdedge.com/internalmedicine/article/214483/osteoporosis/osteoporotic-fracture-risk-undermanaged-older-adults?channel=290
Heidi Splete

Dec 18th, 2019 - Treatment of osteoporosis in older adults at increased risk for fractures declined from 2010 to 2014, based on a study of nearly 900,000 individuals. Courtesy University of Alabama at Birmingham Dr.

Well-tolerated topical capsaicin formulation reduces knee OA pain
https://www.mdedge.com/internalmedicine/article/214467/osteoarthritis/well-tolerated-topical-capsaicin-formulation-reduces?channel=290
Jeff Craven

Dec 18th, 2019 - ATLANTA – Use of high-concentration topical capsaicin was associated with reduced pain, a longer duration of clinical response, and was well tolerated in patients with knee osteoarthritis, compared with lower concentrations of capsaicin and placebo, according to recent research presented at the annual meeting of the American College of Rheumatology. Jeff Craven/MDedge News Tim Warneke While the.

Hydroxychloroquine prevents congenital heart block recurrence in anti-Ro pregnancies
https://www.mdedge.com/internalmedicine/article/214451/lupus-connective-tissue-diseases/hydroxychloroquine-prevents?channel=290
M. Alexander Otto

Dec 17th, 2019 - ATLANTA – Hydroxychloroquine (Plaquenil) 400 mg/day starting by pregnancy week 10 reduces recurrence of congenital heart block in infants born to women with anti-Ro antibodies, according to an open-label, prospective study presented at the annual meeting of the American College of Rheumatology. M.

ACR and EULAR release first classification criteria for IgG4-related disease
https://www.mdedge.com/internalmedicine/article/214448/lupus-connective-tissue-diseases/acr-and-eular-release-first?channel=290
Jeff Craven

Dec 17th, 2019 - The American College of Rheumatology and the European League Against Rheumatism have released the first classification criteria for IgG4-related disease. Although it was first recognized as a distinct disease in 2003, investigators have since learned that IgG4-related disease (IgG4-RD) is not particularly rare.

VEDOSS study describes predictors of progression to systemic sclerosis
https://www.mdedge.com/dermatology/article/214179/lupus-connective-tissue-diseases/vedoss-study-describes-predictors?channel=39313
Jeff Craven

Dec 12th, 2019 - ATLANTA – Patients with Raynaud’s phenomenon and puffy fingers, disease-specific antibodies, and/or nailfold video capillaroscopy abnormalities were more likely to progress to systemic sclerosis within 5 years than were patients without those features, according to recent results from the Very Early Diagnosis Of Systemic Sclerosis (VEDOSS) study presented at the annual meeting of the American C.

ADA2 is a potent new biomarker for macrophage activation syndrome
https://www.mdedge.com/fedprac/article/214103/pediatrics/ada2-potent-new-biomarker-macrophage-activation-syndrome?channel=285
M. Alexander Otto

Dec 11th, 2019 - ATLANTA – Adenosine deaminase 2 above the upper limit of normal is 86% sensitive and 94% specific for distinguishing macrophage activation syndrome from active systemic juvenile idiopathic arthritis, making it perhaps the most potent blood marker yet identified to differentiate the two, according to a report presented at the annual meeting of the American College of Rheumatology. Dr.

Tofacitinib improves disease activity in patients with polyarticular-course JIA
https://www.mdedge.com/fedprac/article/214064/pediatrics/tofacitinib-improves-disease-activity-patients-polyarticular?channel=285
Jeff Craven

Dec 11th, 2019 - ATLANTA – Treatment of polyarticular-course juvenile idiopathic arthritis with tofacitinib led to significantly fewer disease flares and greater improvement in disease activity than with placebo in a phase 3, multinational, randomized, double-blind, controlled withdrawal study presented at the annual meeting of the American College of Rheumatology. Jeff Craven/MDedge News Dr.